Clinical Trial Update: Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

View source ↗

Summary

This document reports the completion of a post-marketing surveillance study evaluating the safety profile of Atrovent Inhalers in chronic obstructive pulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Atrovent Inhalers (ipratropium bromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED